Role of the liver in hyperlipidemia.

Suppr

超能文献

作者信息

Havel R J

机构信息

Cardiovascular Research Institute, University of California, San Francisco 94143-0130.

出版信息

Semin Liver Dis. 1992 Nov;12(4):356-63. doi: 10.1055/s-2008-1040405.

DOI:10.1055/s-2008-1040405

PMID:1465620

Abstract

摘要

相似文献

Role of the liver in hyperlipidemia.

Semin Liver Dis. 1992 Nov;12(4):356-63. doi: 10.1055/s-2008-1040405.

[Principles of cholesterol and bile acid metabolism in the liver and small intestine (II)].

Leber Magen Darm. 1986 Nov;16(6):358-77.

Absorption and metabolism of dietary cholesterol.

Annu Rev Nutr. 1983;3:71-96. doi: 10.1146/annurev.nu.03.070183.000443.

Origin and fate of lipoproteins.

Adv Exp Med Biol. 1973;38:39-52.

Lipoproteins and heart disease.

Nurse Pract. 1983 May;8(5):68-9, 72.

Low-density lipoprotein (LDL) receptors and the regulation of serum LDL levels.

Neth J Med. 1985;28(2):52-8.

[Hyperlipoproteinemia].

Ned Tijdschr Geneeskd. 1979 Mar 14;123(15):617-28.

[Lipoprotein metabolism].

Rev Med Brux. 1997 Feb;18(1):3-9.

The uptake of chylomicron remnants by the liver.

Adv Exp Med Biol. 1987;210:131-5.

Mechanisms of hyperlipoproteinemia.

Adv Exp Med Biol. 1972;26(0):57-70. doi: 10.1007/978-1-4684-7547-0_4.

引用本文的文献

Microbiome-Metabolome Analysis Insight into the Effects of the Extract of L. on High-Fat Diet-Induced Hyperlipidemia.

Metabolites. 2024 Apr 29;14(5):257. doi: 10.3390/metabo14050257.

Chimeric Peptide Engineered Nanomedicine for Synergistic Suppression of Tumor Growth and Therapy-Induced Hyperlipidemia by mTOR and PCSK9 Inhibition.

Pharmaceutics. 2023 Sep 23;15(10):2377. doi: 10.3390/pharmaceutics15102377.

Initial hepatic removal of chylomicron remnants is unaffected but endocytosis is delayed in mice lacking the low density lipoprotein receptor.

Proc Natl Acad Sci U S A. 1995 May 9;92(10):4611-5. doi: 10.1073/pnas.92.10.4611.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验